Related Experiment Video
Updated: Jun 23, 2026
07:41
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
Identifying novel molecular structures for advanced melanoma by ligand-based virtual screening
Zhao Wang1, Yan Lu, William Seibel
1Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center, Memphis, Tennessee 38163, USA.
Journal of Chemical Information and Modeling
|May 19, 2009
Summary
Researchers explored new anticancer compounds using virtual screening of over 300,000 molecules. This led to novel thiazole analogs with improved potency and selectivity against melanoma cells.
Area of Science:
- Medicinal Chemistry
- Computational Chemistry
- Oncology
Background:
- A novel class of thiazole analogs demonstrates high potency against melanoma.
- Expanding structure-activity relationship (SAR) studies is crucial for developing new cancer therapies.
- Exploring novel molecular scaffolds can lead to improved drug candidates.
Purpose of the Study:
- To identify new molecular scaffolds and expand SAR studies for potent melanoma therapeutics.
- To validate and apply ligand-based virtual screening methods for drug discovery.
- To discover novel anticancer compounds with improved potency and selectivity.
Main Methods:
- Extensive ligand-based virtual screening of a 342,910-compound library.
- Utilized connectivity-based (Pipeline Pilot) and shape similarity (Schrodinger) virtual screening approaches.
- In vitro testing of selected compounds against melanoma cancer cell lines.
Main Results:
- Virtual screening methods successfully ranked similar compounds highly and dissimilar compounds lowly.
- Several identified compounds exhibited good anticancer activity against melanoma cells.
- A newly synthesized analog showed improved potency and selectivity compared to the lead compound.
Conclusions:
- Virtual screening provided valuable insights for structural modifications of lead compounds.
- Novel molecular platforms were identified for optimizing new classes of anticancer agents.
- The study successfully identified promising thiazole analogs for further melanoma drug development.
